Skip to main content
Contact Us
Subscribe
E-Edition
71°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Lyell Immunopharma, Inc
Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting
March 05, 2024
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023
February 28, 2024
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma Announces Participation in March Investor Conferences
February 26, 2024
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanoma
November 09, 2023
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023
November 07, 2023
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma Presentations at SITC Highlight New Nonclinical Data on Product Candidates and Innovative Technology to Shorten TIL Manufacturing
October 31, 2023
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma Announces the Acceptance of Six Abstracts for Presentation at 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
September 27, 2023
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma to Participate in Upcoming Investor Conferences
August 31, 2023
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2023
August 08, 2023
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma Appoints Matthew Lang as Chief Business Officer
July 05, 2023
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
June 07, 2023
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2023
May 04, 2023
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma to Participate in BofA Securities Healthcare Conference
May 02, 2023
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2022
February 28, 2023
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma to Participate in 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma Appoints Lynn Seely, MD as President and Chief Executive Officer
December 15, 2022
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma to Participate in BofA Securities Biotech Conference
December 01, 2022
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma to Participate in Barclays Virtual Fireside Chat Series
November 10, 2022
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma Reports Recent Business Highlights and Third Quarter Financial Results
November 08, 2022
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma Presents New Data at SITC Highlighting its Growing Pipeline of T – Cell Reprogramming Technologies and Product Candidates Targeting Solid Tumors
November 07, 2022
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma to Participate in Credit Suisse Healthcare Conference
November 02, 2022
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma Announces FDA Clearance of its IND for LYL845, a TIL Product Candidate Enhanced with its Novel Epigenetic Reprogramming Technology for Solid Tumors
October 06, 2022
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma to Present Preclinical Data Highlighting New T-Cell Reprogramming Technologies and its Growing Pipeline at 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 05, 2022
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Lyell Immunopharma Announces the Appointment of Rahsaan Thompson as Chief Legal Officer
September 28, 2022
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tickers
LYEL
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.